POLISCOPE
Back to feed
Part ofHealth →

The civic record

Read. Follow. Verify.
High Impact

1971 Senate Hearings on the National Sickle Cell Anemia Prevention Act

Original title: National sickle cell anemia prevention act: hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety-second Congress, first session on S. 2676 ... November 11 and 12, 1971.

Record date · July 20, 2026

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

This document contains the official transcript of Senate hearings held on November 11 and 12, 1971, regarding , a proposed bill to establish a national program for the prevention and treatment of sickle cell anemia.

Why it matters

The hearings represent the legislative foundation for federal funding and research initiatives specifically targeting sickle cell anemia, which directly impacted the allocation of government resources for genetic disease screening and patient care.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Medical research community

The legislation proposed in the hearings would determine the scope and funding of federal research into sickle cell anemia.

Directly affected

Patients with sickle cell anemia

The proposed act aimed to establish national programs for the prevention and treatment of the condition.

Key Facts

  • The hearings were conducted by the Subcommittee on Health of the Committee on Labor and Public Welfare.
  • The subject of the hearings was the review of S. 2676, the National Sickle Cell Anemia Prevention Act.
  • The hearings took place over two days: November 11 and 12, 1971.
  • The purpose of the legislation was to create a national framework for preventing and treating sickle cell anemia.

Frequently Asked Questions

What was the purpose of these hearings?
The hearings were held to gather testimony and information regarding , a bill aimed at establishing a national program to address sickle cell anemia.
When did these hearings take place?
The hearings were held on November 11 and 12, 1971.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Federalization of Genetic Disease Research

The hearings mark a specific point in 1971 where the federal government moved to centralize the response to a specific genetic condition through dedicated legislation.

Connected Entities

Subcommittee on Health of the Committee on Labor and Public Welfare
OrganizationSubcommittee on Health of the Committee on Labor and Public Welfare“The Senate body responsible for conducting the hearings.”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance80
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz5
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record